Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L10 pseudogene 14 (RPL10P14) is a processed pseudogene matching the sequence of the functional ribosomal protein L10 gene (RPL10), but it does not encode a functional protein and is not known to be expressed or involved in any biological, pathological, or pharmacological processes. Processed pseudogenes like RPL10P14 are genomic sequences similar to real genes but have lost their protein-coding ability due to mutation or truncation. RPL10P14 is not classified as a therapeutic target, receptor, enzyme, transporter, or functional ribosomal protein and is instead considered a nonfunctional remnant in the genome[1]. Details and Rationale: - RPL10P14 is explicitly annotated as a pseudogene in multiple authoritative sources[1]. It is not a protein-coding gene and has no known biological or disease relevance. - There is no evidence in the curated biomedical literature or databases that RPL10P14 is a drug target, encodes a receptor, or acts in any pharmacological, regulatory, or biomarker capacity[1]. - The main functional ribosomal protein L10 (RPL10) is protein-coding, present on the X chromosome, and has paralogs such as RPL10L and multiple processed pseudogenes[6][8]. However, RPL10P14 itself is a non-functional pseudogene, sharing sequence similarity with RPL10 but not encoding a protein product[1][7]. - Aliases: No additional aliases were found beyond those derived directly from its systematic nomenclature. - Molecular classification: Because pseudogenes are not classified with protein families such as "Ribosomal protein" in a functional sense, the most accurate category is "Other.” - Biological function, disease role, drug interactions, mechanism of action, biomarker status, and safety profile: All null or not applicable for pseudogenes[1]. Summary: RPL10P14 is a processed pseudogene, not a functional gene product, druggable target, or relevant biomolecule for pharmacological or disease processes. Its only recognized role is as a remnant of evolutionary gene duplication/loss events[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L10 pseudogene 14 (RPL10P14).